Activase

• “Genentech Inc. won approval for TPA in 1996 under the U.S. brand name Activase, but despite high hopes -- and portrayals as a miracle on the television drama "ER" -- fewer than 5% of stroke patients currently receive it.”

  The Wall Street Journal: Clot-Busting Drug Should Be Used

• “Tarceva, or on Activase, which is used to dissolve blood clots in”

  NYT > Home Page

• “Alteplase is marketed under the brand name Activase® in the U.S.A. by Genentech, Inc. and in Canada by Roche Canada, where it has been used extensively for the treatment of acute ischaemic stroke since 1996 and 1999, respectively.”

  Health News from Medical News Today

• “Genentech's sales of Activase and related clot-busters were about $268 million in the U.S. last year.”

  The Wall Street Journal: Clot-Busting Drug Should Be Used

• “Genentech The stroke drug Activase should be used in more patients, a study found.”

  The Wall Street Journal: Clot-Busting Drug Should Be Used

• “Vulnerable biopharmaceuticals include Amgen's Epogen, which treats anemia in patients with chronic renal failure, and Genetech's Activase, for heart attacks, strokes and pulmonary embolisms.”

  Forbes: Six Picks In Generic Drugs

• “The company's wide range of products also includes Activase and TNKase for cardiovascular treatments.”

  Forbes: The Week Ahead: April 10-14People To Watch: The Week Ahead

• “It followed 3,339 patients who had been treated for heart attacks with tissue plasminogen activator (Activase), a drug made by Genentech Inc.”

  ANC Daily News Briefing

• “*Development and execution of the 3-year brand plan and the 1 year tactical plan for Activase”

  product management Jobs in San Francisco, CA 94118 | Indeed.com

• “Coordination & integration of marketing plans and activities to grow Activase and leadership of planning activities facilitating the launch of an expanded label, Activase for”

  product management Jobs in San Francisco, CA 94118 | Indeed.com

Show 10 more examples...